Lyra Therapeutics Stock Price on December 24, 2024
| LYRA Stock | USD 0.21 0.01 4.55% |
Below is the normalized historical share price chart for Lyra Therapeutics extending back to May 01, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lyra Therapeutics stands at 0.21, as last reported on the 3rd of January, with the highest price reaching 0.21 and the lowest price hitting 0.18 during the day.
If you're considering investing in Lyra Stock, it is important to understand the factors that can impact its price. At this point, Lyra Therapeutics is very risky. Lyra Therapeutics has Sharpe Ratio of 0.0164, which conveys that the firm had a 0.0164% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Lyra Therapeutics, which you can use to evaluate the volatility of the firm. Please verify Lyra Therapeutics' Risk Adjusted Performance of 0.0065, mean deviation of 4.42, and Standard Deviation of 6.71 to check out if the risk estimate we provide is consistent with the expected return of 0.11%.
At present, Lyra Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 60.1 M, whereas Common Stock Total Equity is forecasted to decline to about 10.4 K. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.13, whereas Price To Sales Ratio is forecasted to decline to 105.86. Lyra Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of May 2020 | 200 Day MA 1.1528 | 50 Day MA 0.2165 | Beta (0.04) |
Lyra |
Sharpe Ratio = 0.0164
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | LYRA |
| Negative Returns |
Estimated Market Risk
| 6.8 actual daily | 60 60% of assets are less volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Lyra Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lyra Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.6552 | Enterprise Value Ebitda 0.6593 | Price Sales 9.1845 | Shares Float 41.7 M | Wall Street Target Price 1.25 |
Related Headline
Assembly Biosciences Headline on 24th of December 2024
Opposition seeks to oust acting president for blocking probe... by koreatimes.co.kr
The main opposition Democratic Party of Korea said Tuesday that it will immediately seek to impeach acting President and Prime Minister Han Duck-soo after he refused to meet the partys demand to promulgate special investigation bills targeting President Yoon Suk Yeol and first lady Kim Keon Hee by Christmas Eve.
Lyra Therapeutics Valuation on December 24, 2024
It is possible to determine the worth of Lyra Therapeutics on a given historical date. On December 24, 2024 Lyra was worth 0.17 at the beginning of the trading date compared to the closed value of 0.17. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lyra Therapeutics stock. Still, in general, we apply an absolute valuation method to find Lyra Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lyra Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lyra Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.19 | 0.19 | 0.16 | 0.17 | 1,211,348 | |
12/24/2024 | 0.17 | 0.18 | 0.17 | 0.17 | 610,736 |
| 0.18 | 0.19 | 0.17 | 0.18 | 1,427,762 |
| Backtest Lyra Therapeutics | | | Lyra Therapeutics History | | | Lyra Therapeutics Valuation | Previous | Next |
Lyra Therapeutics Trading Date Momentum on December 24, 2024
| On December 26 2024 Lyra Therapeutics was traded for 0.18 at the closing time. The top price for the day was 0.19 and the lowest listed price was 0.17 . The trading volume for the day was 1.4 M. The trading history from December 26, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 5.88% . The trading delta at closing time against the current closing price is 23.53% . |
Lyra Therapeutics Fundamentals Correlations and Trends
By evaluating Lyra Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lyra Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lyra financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lyra Therapeutics Stock history
Lyra Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lyra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lyra Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lyra Therapeutics stock prices may prove useful in developing a viable investing in Lyra Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 57.3 M | 60.1 M | |
| Net Loss | -49.8 M | -47.3 M |
Lyra Therapeutics Quarterly Net Working Capital |
|
Lyra Therapeutics Stock Technical Analysis
Lyra Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lyra Therapeutics Period Price Range
Low | January 3, 2025
| High |
0.00 | 0.00 |
Lyra Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lyra Therapeutics January 3, 2025 Market Strength
Market strength indicators help investors to evaluate how Lyra Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lyra Therapeutics shares will generate the highest return on investment. By undertsting and applying Lyra Therapeutics stock market strength indicators, traders can identify Lyra Therapeutics entry and exit signals to maximize returns
Lyra Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lyra Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Lyra Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lyra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0065 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.04) | |||
| Treynor Ratio | (0.12) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Lyra Stock analysis
When running Lyra Therapeutics' price analysis, check to measure Lyra Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lyra Therapeutics is operating at the current time. Most of Lyra Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lyra Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lyra Therapeutics' price. Additionally, you may evaluate how the addition of Lyra Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |